Vienna, – 7th of December, 2005, – Salus Alpha – a secure alternative

One knows it from aviation – you do not board an airplane without doubts, since not every operator considers safety the top priority instead of profits.

This is not different in the investment business. Even when the year 2005 provided returns in the green range so far, one should protect himself with a safe investment strategy against possible losses.

The Salus Alpha team focuses constantly on risk. Due to a strict due diligence procedure and an international hedge funds rating, Salus Alpha products offer consistently good results. This is also reflected by the convincing November performance:

The Salus Alpha Equity Market Neutral is the first UCITS fund in the German speaking market which employs a “single hedge funds strategy”. The single manager – single strategy product, which has an European passport, performed +3,63% in November. The fund is a market neutral long/short equity fund. The fund’s investment objective is capital appreciation paired with low to no correlation to US equity markets. Additionally it seeks to realize returns with lower volatility than long-only investments in US equities. The fund invests only in stocks of the S&P 500 and is investing in equities either long or short through derivatives; target return is an annual return of 10 – 15%.

ISIN: AT0000495098

Absolute Return S.A. performed strongly in November with +1,63% and was therefore listed under the Top 4 most visited funds in OnVista`s Online Ranking. Investors are searching for alternatives to traditional investments. Diversification by various styles offers market neutrality and low volatility with appealing returns. Salus Alpha`s portfolio managers have the talent to recognize changes in the market and are therefore able to continuously develop the investment process. ISIN: AT0000648969

Absolute Return S.A. Institutional: This fund`s performance (November +1,23%) depends on the development of the Salus Alpha multi manager – multi strategy portfolio. We select managers, which conform with Salus Alpha’s internal quality standards (internal hedge fund rating). The fund is able to achieve a positive return in rising or falling markets and invests in all Alternative Investment strategies.

ISIN: AT0000626460

The Salus Alpha products are usually structured as UCITS funds with daily net asset value calculation. The products are market neutral and have daily liquidity – the main focus is always on preventing losses.

About Salus Alpha:

Salus Alpha is a Swiss alternative investment management company with subsidiaries in Austria and the United States. Salus Alpha is a pioneer in the area of alternative investment products on basis of daily tradable unit trusts.

Salus Alpha`s portfolio managers and analysts gained long-time experience with investment banks in fund of hedge fund management, before joining Salus Alpha. The Salus Alpha investment process is based upon three equally important criteria: strategy allocation (Top Down), manager allocation (Bottom Up) and continuous monitoring (Risk Management).

For further information, please contact: public.relations@salusalpha.com or

call: +43 (1) 9572587 – 0